IMRX
Immuneering Corp
4.40$
-0.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +20.4% | -10.0% | -84.8% | -99.9% | -100.0% | – | |
| – | +4.7% | -9.9% | -86.3% | +383.3% | -6.6% | -2.0% | |
| – | +48.0% | -10.1% | -82.9% | -581.1% | – | – | |
| – | +250.6% | +76.9% | +36.6% | +14.8% | +15.2% | -12.3% | |
| – | +14.8% | +166.0% | +88.7% | +7.4% | -4.1% | +7.6% | |
| – | +159.2% | +92.2% | +49.1% | +12.5% | +9.7% | -8.4% | |
| – | – | – | – | – | – | – | |
| – | -87.9% | +373.3% | +402.4% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | -124.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.